BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16083159)

  • 1. Clinical manifestations of patients with hyperuricemia.
    Akkasilpa S; Avihingsanon Y; Hanvivadhanakul P; Wonchinsri J
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S41-4. PubMed ID: 16083159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of hyperuricemia in children of Taiwan aborigines.
    Liu CS; Li TC; Lin CC
    J Rheumatol; 2003 Apr; 30(4):841-5. PubMed ID: 12672209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of uric acid management in hypertensive subjects.
    Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
    Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
    Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
    Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients.
    Rodilla E; Pérez-Lahiguera F; Costa JA; González C; Miralles A; Moral D; Pascual JM
    Med Clin (Barc); 2009 Jan; 132(1):1-6. PubMed ID: 19174057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure.
    Niizeki T; Takeishi Y; Arimoto T; Okuyama H; Nozaki N; Hirono O; Tsunoda Y; Watanabe T; Nitobe J; Miyashita T; Takahashi H; Koyama Y; Kubota I
    J Cardiol; 2006 May; 47(5):219-28. PubMed ID: 16764328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
    Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J
    J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rheumatologic manifestations in heart transplant recipients. A cross-sectional study of 365 patients].
    Rozenberg S; Frih L; Lang T; Koeger AC; Cabrol A; Gandjbackch I; Bourgeois P
    Rev Rhum Ed Fr; 1993 Jan; 60(1):10-5. PubMed ID: 8242020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G; Arikan C; Kilic M; Aydogdu S
    Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of uric acid metabolism and gouty arthritis in patients with polycystic kidney.
    Hosoya T; Ichida K; Tabe A; Sakai O
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):43-8. PubMed ID: 8336399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia and the metabolic syndrome in Hangzhou.
    Cai Z; Xu X; Wu X; Zhou C; Li D
    Asia Pac J Clin Nutr; 2009; 18(1):81-7. PubMed ID: 19329400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.
    Baker JF; Schumacher HR; Krishnan E
    Angiology; 2007; 58(4):450-7. PubMed ID: 17875958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary investigation of the association between serum uric acid and impaired renal function.
    Chen YC; Su CT; Wang ST; Lee HD; Lin SY
    Chang Gung Med J; 2009; 32(1):66-71. PubMed ID: 19292941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperuricemia and cardiac risK factors: epidemiologic study in the aged].
    Cadeddu G; Fioravanti P; Antonicelli R; Gasparrini PM; Gaetti R
    Minerva Cardioangiol; 1995; 43(1-2):29-34. PubMed ID: 7792016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gouty arthritis in acute cerebrovascular disease.
    Lin YH; Hsu HL; Huang YC; Lee M; Huang WY; Huang YC; Lee TH; Lee JD
    Cerebrovasc Dis; 2009; 28(4):391-6. PubMed ID: 19696479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.